Definitive Contract 75N95024C00042
Award Date
9/30/24
Potential Completion Date
3/30/30
Potential Value
$12M
Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Camden, NJ 08103, USA
Solicitation Procedures
Two Step
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to the Coriell Institute for Medical Research, Inc., a non-profit organization, to continue operating the NINDS Human Genetics Resource Center. The contract, which does not have a set-aside designation, is valued at $10,470,137.56 and runs through September 29, 2024. The contract involves the Coriell Institute receiving, processing, storing, and...
This is a federal contract award from the National Institute of Mental Health (NIMH), a civilian agency, to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center. The contract is for scientific management and support services to the NIMH Repository and Genomics Resource (NRGR). The contract does not have a set-aside designation. The definitive contract has a ceiling value of $48,265,314.00 and a period of performance ending on February 10, 2031. Coriell...
This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
This is a $7,985,296.56 definitive cost-no-fee contract awarded by the National Institute on Aging (NIA) to the Coriell Institute for Medical Research, Inc. The contract is for the selection, production, characterization, and distribution of cultured cells to support research on aging. Coriell, an independent non-profit biomedical research center, has extensive expertise in areas such as genomics, cell culture, and biospecimen management, making it a valuable partner for the NIA's research...
The National Institute on Aging (NIA) awarded a 5-year, $10,513,138 definitive contract to the Coriell Institute for Medical Research, Inc. to continue operating an aging cell repository that provides well-characterized cell lines and DNA to researchers studying the biology of aging. The contract supports maintaining existing cell stocks, establishing new cell lines, isolating DNA, and distributing materials to investigators. There is no set-aside designation for this award. Coriell Institute,...
This federal contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to the University of Miami to establish a collection site (the NIH Brain and Tissue Repository) that will actively acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The $25,542,514.53 contract is for a definitive, cost-no-fee...
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...
The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), has awarded a $20,000 firm-fixed-price purchase order contract to Transnetyx, Inc. for genotyping services to support biomedical research efforts. Transnetyx, a for-profit organization, will provide automated DNA extraction, multi-gene analysis, and bioinformatics support for projects related to neurological disorders, environmental health, substance abuse, and age-related diseases....
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...
This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...